You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Amylin

Showing 1 - 25 of 188
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Obesity Trial in Portland (Pramlintide (Amylin), Placebo (Normal Saline), 2 Metreleptin)

Active, not recruiting
  • Obesity
  • Pramlintide (Amylin)
  • +3 more
  • Portland, Oregon
    Oregon Health & Science University
Jul 27, 2021

A Causative Role for Amylin in Diabetic Peripheral Neuropathy

Recruiting
  • Type2 Diabetes
  • Peripheral Neuropathy
    • Lexington, Kentucky
    • +1 more
    Apr 23, 2021

    Type 1 Diabetes Trial in Charlottesville (Basal insulin alone, Basal pramlintide and reduced basal insulin, CGM)

    Terminated
    • Type 1 Diabetes Mellitus
    • Basal insulin alone
    • +5 more
    • Charlottesville, Virginia
      University of Virginia Center for Diabetes Technology
    Mar 10, 2022

    Euglycemia, Hypoglycemia, Hyperglycemia Trial in Philadelphia (Exenatide 0.27 ng/kg/min, Exenatide 0.41 ng/kg/min, Placebo)

    Completed
    Has Results
    • Euglycemia
    • +2 more
    • Exenatide 0.27 ng/kg/min
    • +2 more
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Dec 21, 2021

    Diabetes Trial in San Antonio (metformin\pioglitazone\exenatide, metformin, glyburide and glargine)

    Active, not recruiting
    • Diabetes
    • San Antonio, Texas
      Texas Diabetes Institute
    Mar 8, 2022

    Type 2 Diabetes Trial (Pramlintide acetate, Placebo)

    Withdrawn
    • Type 2 Diabetes
    • Pramlintide acetate
    • Placebo
    • (no location specified)
    Jul 18, 2021

    Migraine Without Aura Trial in Glostrup (Amylin (Pramlintide), CGRP)

    Completed
    • Migraine Without Aura
    • Amylin (Pramlintide)
    • CGRP
    • Glostrup, Denmark
      Danish Headache Center
    Jun 23, 2020

    Type 1 Diabetes, Type 2 Diabetes Trial in Austin (I-PORT, standard injections)

    Terminated
    Has Results
    • Type 1 Diabetes
    • Type 2 Diabetes
    • I-PORT
    • standard injections
    • Austin, Texas
      Texas Diabetes & Endocrinology, PA
    Sep 28, 2020

    Healthy Volunteers, Overweight Trial in Nottingham (GUB014295, GUB014295-PLACEBO)

    Recruiting
    • Healthy Volunteers
    • Overweight
    • Nottingham, United Kingdom
      Quotient Sciences
    Nov 23, 2023

    Diabetes, Type 1, Type 1 Diabetes, Postprandial Hyperglycemia Trial in Montreal (Rapid-Acting Insulin, Placebo, Pramlintide

    Recruiting
    • Diabetes Mellitus, Type 1
    • +2 more
    • Rapid-Acting Insulin
    • +3 more
    • Montreal, Quebec, Canada
      McGill University Health Centre
    Dec 9, 2021

    Hypothalamic Obesity Trial in Orange, Saint Paul (Exenatide)

    Completed
    Has Results
    • Hypothalamic Obesity
    • Orange, California
    • +1 more
    Sep 24, 2019

    Type 1 Diabetes Trial in Dallas (Leptin)

    Terminated
    Has Results
    • Type 1 Diabetes
    • Dallas, Texas
      UT Southwestern Medical Center
    Jul 17, 2019

    HIV, Lipodystrophy Trial in Dallas (Leptin, Placebo)

    Completed
    Has Results
    • HIV Infections
    • Lipodystrophy
    • Dallas, Texas
      UT Southwestern Medical Center
    May 7, 2019

    Alzheimer, Mild Cognitive Impairment Trial in Indianapolis, Boston, Jamaica Plain (Pramlintide challenge test)

    Recruiting
    • Alzheimer Disease
    • Mild Cognitive Impairment
    • Pramlintide challenge test
    • Indianapolis, Indiana
    • +2 more
    Jan 27, 2022

    Chronic Migraine Trial (KOS (Intranasal kinetic oscillation stimulation))

    Not yet recruiting
    • Chronic Migraine
    • KOS (Intranasal kinetic oscillation stimulation)
    • (no location specified)
    Apr 14, 2022

    Obese Trial in Timisoara (Glucose 8 g coated beads (47% w/w), Glucose 12 g coated beads (47% w/w), Glucose 16 g coated beads

    Completed
    • Obese
    • Glucose 8 g coated beads (47% w/w)
    • +4 more
    • Timisoara, Romania
      NovaClin Medical Research Center S.R.L
    Feb 17, 2023

    Obesity Trial in San Diego (ARD-101, Placebo)

    Completed
    • Obesity
    • San Diego, California
      Altman Clinical and Translational Research Institute, University
    Jan 12, 2023

    Healthy, Inflammation, Aging Trial in Oslo (Eggshell membrane (ESM), Placebo)

    Completed
    • Healthy
    • +2 more
    • Eggshell membrane (ESM)
    • Placebo
    • Oslo, Norway
      University of Oslo
    Jan 5, 2022

    Polycystic Ovary Syndrome Patients

    Completed
    • Polycystic Ovary Syndrome
    • preptin and amylin level
    • Rize, Turkey
      Recep Tayyip Erdogan University
    Jul 13, 2018

    Schizophrenia, Schizoaffective Disorder, Diabetes Trial in Dallas (Pramlintide, Placebo)

    Completed
    Has Results
    • Schizophrenia
    • +3 more
    • Dallas, Texas
      The University of Texas Southwestern Medical Center
    Nov 14, 2018

    Type 1 Diabetes, Type 1 Diabetes, Hyperglycemia, Postprandial Trial in Montreal (Fiasp, Pramlintide Acetate, Placebo)

    Active, not recruiting
    • Type 1 Diabetes
    • +2 more
    • Montreal, Quebec, Canada
      3555 University Street
    Jan 6, 2022

    Bariatric Surgery, Obesity, Weight Gain Trial in San Diego (ARD-101)

    Recruiting
    • Bariatric Surgery
    • +2 more
    • San Diego, California
      Altman Clinical and Translational Research Institute, University
    Apr 21, 2022

    Amino Acid Trial in Bobigny (Whey Protein Isolate 894 Fonterra, Zein Sigma-Aldrich W555025, Protein-free test-meal)

    Completed
    • Amino Acid
    • Whey Protein Isolate 894 Fonterra
    • +2 more
    • Bobigny, France
      CRNH Ile de France
    May 31, 2022

    Obesity Trial in Quebec City (Low-fat dairy products, Full-fat dairy products)

    Recruiting
    • Obesity
    • Low-fat dairy products
    • Full-fat dairy products
    • Quebec City, Quebec, Canada
      Laval University
    Jun 9, 2022

    Impaired Glucose Tolerance Trial in Oslo (Salmon fishmeal, Microcrystalline cellulose)

    Completed
    • Impaired Glucose Tolerance
    • Salmon fishmeal
    • Microcrystalline cellulose
    • Oslo, Post Box 1046, Blindern, Norway
      University of Oslo
    Sep 27, 2021